Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pietschmann

Showing results (121-130 of 210) with videos related to

Pageof 21
Sort By:
Biorxiv : the Preprint Server for Biology|December 4, 2023
Hepatitis C virus cell culture adaptive mutations enhance cell culture propagation by multiple mechanisms but boost antiviral responses in primary human hepatocytesNicola Frericks, Richard J P Brown, Birthe M Reinecke, et al.
BMC Pulmonary Medicine|March 16, 2022
IRIS: Infection with RespIratory Syncytial Virus in infants-a prospective observational cohort studyMartin Wetzke, Dominik Funken, Mathias Lange, et al.
Plos One|October 11, 2012
Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virusAsim Ejaz, Eike Steinmann, Zoltán Bánki, et al.
Journal of Virology|February 6, 2024
Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytesNicola Frericks, Richard J P Brown, Birthe M Reinecke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Challenge Inoculum for Hepatitis C Virus Controlled Human Infection ModelT Jake Liang, John L M Law, Thomas Pietschmann, et al.
Virus Research|February 26, 2018
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agenciesRalf Bartenschlager, Thomas F Baumert, Jens Bukh, et al.
The Journal of Infectious Diseases|September 27, 2013
Inactivation of hepatitis C virus infectivity by human breast milkStephanie Pfaender, Julia Heyden, Martina Friesland, et al.
Cell Host & Microbe|October 14, 2016
cGAS-Mediated Innate Immunity Spreads Intercellularly through HIV-1 Env-Induced Membrane Fusion SitesShuting Xu, Aurélie Ducroux, Aparna Ponnurangam, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoproteinSandra Westhaus, Dorothea Bankwitz, Stefanie Ernst, et al.
Hepatology (Baltimore, Md.)|August 13, 2011
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entrySandra Ciesek, Thomas von Hahn, Che C Colpitts, et al.
Pageof 21

Showing results (121-130 of 210) with videos related to

Sort By:
Pageof 21
Biorxiv : the Preprint Server for Biology|December 4, 2023
Hepatitis C virus cell culture adaptive mutations enhance cell culture propagation by multiple mechanisms but boost antiviral responses in primary human hepatocytesNicola Frericks, Richard J P Brown, Birthe M Reinecke, et al.
BMC Pulmonary Medicine|March 16, 2022
IRIS: Infection with RespIratory Syncytial Virus in infants-a prospective observational cohort studyMartin Wetzke, Dominik Funken, Mathias Lange, et al.
Plos One|October 11, 2012
Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virusAsim Ejaz, Eike Steinmann, Zoltán Bánki, et al.
Journal of Virology|February 6, 2024
Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytesNicola Frericks, Richard J P Brown, Birthe M Reinecke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Challenge Inoculum for Hepatitis C Virus Controlled Human Infection ModelT Jake Liang, John L M Law, Thomas Pietschmann, et al.
Virus Research|February 26, 2018
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agenciesRalf Bartenschlager, Thomas F Baumert, Jens Bukh, et al.
The Journal of Infectious Diseases|September 27, 2013
Inactivation of hepatitis C virus infectivity by human breast milkStephanie Pfaender, Julia Heyden, Martina Friesland, et al.
Cell Host & Microbe|October 14, 2016
cGAS-Mediated Innate Immunity Spreads Intercellularly through HIV-1 Env-Induced Membrane Fusion SitesShuting Xu, Aurélie Ducroux, Aparna Ponnurangam, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoproteinSandra Westhaus, Dorothea Bankwitz, Stefanie Ernst, et al.
Hepatology (Baltimore, Md.)|August 13, 2011
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entrySandra Ciesek, Thomas von Hahn, Che C Colpitts, et al.
Pageof 21